Infinity Pharmaceuticals, Inc. (INFI) Misses Q1 EPS by 3c

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $26.18 million.

For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Firm Capital Apartment REIT posts Q2 loss, plans name change
• Walmart shares fall despite earnings beat